Visualitza per autor "SHIH, JIN-YUAN"
Ara mostrant els elements 1-1 d 1
-
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
Wang, Jie F.; Wang, Yan; Lee, Se-hoon; Melosky, Barbara; SHIH, JIN-YUAN; PASSARO, ANTONIO; FELIP, ENRIQUETA (Elsevier, 2024-01)